TP53 and pulmonary fibrosis: A recent study in vivo and in vitro has proved that in addition to repress self-renewal of AT2 cells by inducing cell cycle arrest, the activation of p53-p21 pathway can disrupt the p300–β-catenin interaction and prevent AT2–to–AT1 cell differentiation, all of which leading to pulmonary fibrosis [101].